Preferred Conversation Topics with Respect to Treatment Decisions Among Individuals with Type 2 Diabetes.
Anna TichlerDorijn F L HertroijsDirk RuwaardMartijn C G J BrouwersMickaël J C HiligsmannJudith D De JongArianne Mathilda Josephus ElissenPublished in: Patient preference and adherence (2023)
In general, individuals with type 2 diabetes not only want to discuss the biological effects of treatments, but also the impact of treatment on their quality of life. Healthcare providers should be aware that attributes are viewed differently by different individuals. This emphasizes the need for tailor-made healthcare decisions, which means eliciting and responding to individual preferences in the decision-making process.